Forum Diskusi dan Komunitas Online

Artificial intelligence is becoming one of the biggest drivers of innovation in oncology. Healthcare providers now rely on AI to analyse medical images, pathology reports, genomic data, laboratory results, and Electronic Health Records (EHRs) to support earlier diagnosis, personalised treatment planning, and better clinical decision-making. As cancer care becomes increasingly data-driven, many hospitals, research institutions, and healthcare startups are looking for experienced software development partners capable of building secure, scalable AI oncology platforms.
After researching companies working across healthcare AI, enterprise software, interoperability, and oncology technology, I put together a list of firms that consistently stand out in this space. While each company has different strengths, they all have experience delivering complex healthcare software powered by artificial intelligence.
1. Idea Usher
Idea Usher focuses on custom AI healthcare software and has developed solutions across diagnostics, medical imaging, telemedicine, remote patient monitoring, healthcare analytics, and enterprise healthcare platforms. Rather than developing standalone AI models, the company builds complete digital healthcare ecosystems where artificial intelligence integrates with cloud infrastructure, clinician workflows, Electronic Health Records, and healthcare interoperability standards.
Its approach to oncology platform development centres on combining pathology reports, radiology images, laboratory findings, genomic information, and patient histories within a single intelligent platform. The company also places significant emphasis on scalability, intuitive user experiences, and long-term product evolution, making it a strong choice for organisations building modern oncology software.
2. ScienceSoft
ScienceSoft has extensive experience modernising enterprise healthcare systems and integrating AI into existing hospital environments. Its healthcare expertise includes Electronic Health Records, laboratory information systems, interoperability platforms, patient portals, analytics, and enterprise software development.
One of its biggest strengths is healthcare integration. Oncology platforms often depend on data collected across multiple departments, including radiology, pathology, pharmacy, and laboratory systems. ScienceSoft has significant experience connecting these environments while maintaining security and regulatory compliance.
3. LeewayHertz
LeewayHertz has established itself as an AI-focused software engineering company with expertise in machine learning, generative AI, computer vision, natural language processing, and predictive analytics. Healthcare organisations looking for advanced AI capabilities often consider the company because artificial intelligence forms the foundation of many of its software solutions.
Its healthcare work includes medical image analysis, predictive healthcare analytics, intelligent document processing, conversational AI, and workflow automation. This makes LeewayHertz particularly relevant for oncology platforms requiring tumour detection, pathology analysis, genomic interpretation, or AI-assisted clinical decision support.
4. Softeq
Softeq brings a different perspective by combining healthcare software with connected medical devices, embedded systems, cloud engineering, and Internet of Medical Things (IoMT) technologies. Modern oncology increasingly depends on information collected from diagnostic equipment, laboratory automation, wearable devices, and patient monitoring systems.
The company's experience developing connected healthcare ecosystems makes it a strong option for organisations building oncology platforms that need to integrate data from multiple medical technologies while maintaining reliable performance and healthcare-grade security.
5. Yalantis
Yalantis is well known for healthcare product engineering with a strong emphasis on usability and workflow optimisation. The company develops software that fits naturally into clinical environments rather than creating systems that require clinicians to change their existing workflows.
Its healthcare portfolio includes telemedicine, care coordination, interoperability, workflow automation, patient engagement, and remote monitoring solutions. For oncology platforms, this translates into software that presents AI-generated recommendations in ways that are practical and easy for clinicians to use during daily patient care.
6. BairesDev
BairesDev provides highly scalable engineering teams capable of supporting healthcare software projects throughout their lifecycle. Instead of specialising in a single technology area, the company offers expertise across artificial intelligence, cloud engineering, backend development, cybersecurity, DevOps, mobile applications, and quality assurance.
Many oncology platforms continue expanding after their initial release, incorporating new diagnostic capabilities, research modules, imaging tools, or precision medicine features. BairesDev's flexible engineering model supports this long-term product evolution without requiring organisations to rebuild their technical teams.
7. Intellias
Intellias specialises in enterprise healthcare architecture, cloud infrastructure, interoperability, and healthcare data engineering. AI platforms depend heavily on high-quality clinical data, and Intellias focuses on building the technical foundations that allow healthcare organisations to process and analyse information securely across multiple hospital systems.
Its expertise includes cloud-native healthcare platforms, enterprise analytics, interoperability frameworks, cybersecurity, and healthcare data platforms. This makes the company particularly suitable for organisations building enterprise-scale oncology solutions.
8. Cognizant
Cognizant approaches oncology software from the perspective of enterprise healthcare transformation. The company works extensively with healthcare providers, pharmaceutical companies, and life sciences organisations to modernise clinical operations through artificial intelligence, analytics, cloud technologies, and workflow automation.
Its experience delivering large healthcare transformation programmes makes it particularly valuable for organisations implementing AI across multiple oncology departments or hospital networks rather than building isolated applications.
9. Accenture
Accenture is one of the world's largest healthcare consulting and technology firms. Its healthcare practice combines artificial intelligence, enterprise architecture, cloud computing, interoperability, cybersecurity, and digital transformation to build scalable healthcare ecosystems.
For oncology projects, Accenture is often chosen by larger healthcare organisations seeking enterprise-wide platforms capable of integrating imaging, pathology, genomics, precision medicine, patient engagement, and clinical decision support into a single solution.
10. Globant
Globant combines AI engineering with digital product design to develop healthcare platforms that prioritise both technical performance and clinician experience. The company focuses on making complex AI insights understandable and actionable within everyday healthcare workflows.
Its healthcare portfolio includes predictive analytics, AI-powered healthcare applications, clinician-facing software, intelligent workflow systems, and cloud-native healthcare products. This combination of engineering and user experience makes Globant a strong choice for organisations building clinician-centred oncology platforms.
Final Thoughts
Choosing the right AI oncology platform development company depends largely on your objectives. Some organisations require enterprise healthcare integration, while others prioritise AI research, medical imaging, clinician usability, cloud infrastructure, or long-term product scalability.
The companies listed above all bring valuable capabilities to oncology software development, but their strengths differ considerably. Before selecting a development partner, it is worth evaluating their healthcare experience, interoperability expertise, AI engineering capabilities, regulatory knowledge, and ability to support continuous product evolution. As AI continues to reshape cancer care, organisations that invest in robust, scalable oncology platforms today will be better positioned to support clinicians, improve operational efficiency, and deliver more personalised care in the years ahead.

Artificial Intelligence in the Fight Against Cancer: A New Era in Medicine

Cancer remains one of the greatest threats to human health. Traditional treatments—surgery, chemotherapy, and radiation therapy—have proven effective, but they are often accompanied by severe side effects and do not always take into account the individual characteristics of the body. In recent years, a true revolution has been taking place in medicine, driven by the introduction of artificial intelligence (AI) technologies. The use of neural networks and machine learning is opening up entirely new horizons in diagnosis, treatment selection, and the development of drugs to fight cancer.

1. Early Diagnosis and Accurate Imaging
One of the key factors in successful cancer treatment is detecting the disease in its earliest stages. Artificial intelligence is demonstrating phenomenal results in the analysis of medical images—CT scans, MRIs, mammograms, and X-rays.

Neural networks trained on millions of images are capable of detecting microscopic changes in tissues that the human eye might miss due to fatigue or the high complexity of the image. For example, when analyzing mammograms, AI helps identify lesions in their early stages, reducing the rate of false negatives and false positives.

How it works: AI compares a patient’s current images with a vast database of pathologies, instantly highlighting suspicious areas for the radiologist. The doctor receives a “second opinion,” which significantly improves diagnostic accuracy.

2. Personalized Medicine and Treatment Selection
Every tumor is unique, as it has its own set of genetic mutations. What helps one patient may prove completely ineffective for another. This is where AI demonstrates its greatest strength—in the concept of personalized (targeted) oncology.

Machine learning algorithms are capable of analyzing vast amounts of data:

A patient’s tumor genetic profile;

Medical history and comorbidities;

Blood test results and biomarkers;

Data on the effectiveness of various treatment regimens in thousands of other patients with similar mutations.

Based on this analysis, AI suggests the most optimal combination of drugs to the oncologist. This avoids the “trial-and-error” approach, saving the patient’s precious time and minimizing the toxic burden on the body.

3. Precision Radiation Therapy
When performing radiation therapy, it is critically important to direct the radiation precisely at the tumor without affecting healthy tissues and vital organs. In the past, radiologists spent long hours manually creating radiation treatment plans.

Today, AI systems can build a 3D model of the tumor and calculate the ideal radiation angle and dose in a matter of minutes. Moreover, AI takes into account the patient’s body movements during breathing in real time, adjusting the beam direction directly during the procedure.

4. Development of New Anticancer Drugs
Developing a new cancer drug traditionally takes 10–15 years and requires billions in investment. Artificial intelligence dramatically accelerates this process.

Using deep learning algorithms (such as protein structure prediction systems), scientists can:

Simulate the interaction of molecules in future drugs with mutated proteins in cancer cells;

Predict effective chemical compounds even before they are synthesized in the laboratory;

Find new uses for existing, approved drugs (drug repurposing).

This reduces the initial drug development phase from several years to just a few months.

The Future of AI in Oncology: The Doctor and the Algorithm
It is important to understand that artificial intelligence does not replace the oncologist but serves as a highly accurate tool for them. The final decision on treatment always rests with the human doctor. AI takes on the routine analysis of vast amounts of data, freeing up the doctor’s time to communicate with the patient and make strategic decisions.

The integration of artificial intelligence into oncology is already saving thousands of lives today, transforming cancer from a fatal diagnosis into a manageable chronic disease. With each passing year, as data accumulates and algorithms improve, medicine is becoming increasingly accurate, safe, and effective. You can learn about this and much more at https://ways2well.com/.